Multivariate analyses for transplant outcomes
| . | OS . | DFS . | Relapse . | NRM . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HR . | 95% CI . | P value . | HR . | (95% CI) . | P value . | HR . | (95% CI) . | P value . | HR . | (95% CI) . | P value . | |
| Age at transplant, y | ||||||||||||
| 40-49 vs <40 | 0.986 | (0.573-1.699) | .961 | 0.872 | (0.520-1.463) | .604 | 0.656 | (0.317-1.356) | .255 | 1.251 | (0.532-2.943) | .608 |
| 50-59 vs <40 | 1.778 | (1.114-2.837) | .016∗ | 1.486 | (0.957-2.306) | .078 | 0.894 | (0.500-1.596) | .704 | 2.501 | (1.201-5.205) | .014∗ |
| ≥60 vs <40 | 2.649 | (1.542-4.550) | <.001∗ | 1.838 | (1.082-3.122) | .024∗ | 0.491 | (0.190-1.265) | .141 | 3.513 | (1.621-7.610) | .001∗ |
| Sex, male vs female | 1.562 | (1.072-2.274) | .020∗ | 1.532 | (1.062-2.208) | .022 | 1.085 | (0.669-1.759) | .740 | 2.030 | (1.124-3.668) | .019∗ |
| ECOG PS, ≥2 vs 0-1 | 3.049 | (1.721-5.403) | <.001∗ | 3.023 | (1.709-5.347) | <.001 | 1.663 | (0.757-3.654) | .206 | 1.754 | (0.605-5.079) | .301 |
| Cytogenetics of MPAL, BCR::ABL1-neg vs -pos | 1.639 | (1.019-2.636) | .042∗ | 1.641 | (1.046-2.574) | .031∗ | 1.384 | (0.741-2.586) | .308 | 1.651 | (0.854-3.193) | .136 |
| Disease status at transplant | ||||||||||||
| CR2 vs CR1 | 1.642 | (0.802-3.362) | .175 | 1.458 | (0.743-2.861) | .273 | 1.119 | (0.429-2.921) | .818 | 1.703 | (0.764-3.796) | .193 |
| CR3 or higher/nCR vs CR1 | 4.008 | (2.614-6.146) | <.001∗ | 3.644 | (2.426-5.475) | <.001∗ | 4.006 | (2.382-6.736) | <.001∗ | 1.027 | (0.493-2.140) | .943 |
| Conditioning | ||||||||||||
| TCI intermediate vs high | 1.067 | (0.652-1.744) | .796 | 1.160 | (0.733-1.836) | .526 | 0.856 | (0.381-1.926) | .707 | 1.305 | (0.695-2.448) | .408 |
| TCI low vs high | 2.493 | (1.212-5.129) | .013∗ | 2.587 | (1.190-5.622) | .016∗ | 2.233 | (0.648-7.693) | .203 | 1.434 | (0.371-5.535) | .601 |
| . | OS . | DFS . | Relapse . | NRM . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HR . | 95% CI . | P value . | HR . | (95% CI) . | P value . | HR . | (95% CI) . | P value . | HR . | (95% CI) . | P value . | |
| Age at transplant, y | ||||||||||||
| 40-49 vs <40 | 0.986 | (0.573-1.699) | .961 | 0.872 | (0.520-1.463) | .604 | 0.656 | (0.317-1.356) | .255 | 1.251 | (0.532-2.943) | .608 |
| 50-59 vs <40 | 1.778 | (1.114-2.837) | .016∗ | 1.486 | (0.957-2.306) | .078 | 0.894 | (0.500-1.596) | .704 | 2.501 | (1.201-5.205) | .014∗ |
| ≥60 vs <40 | 2.649 | (1.542-4.550) | <.001∗ | 1.838 | (1.082-3.122) | .024∗ | 0.491 | (0.190-1.265) | .141 | 3.513 | (1.621-7.610) | .001∗ |
| Sex, male vs female | 1.562 | (1.072-2.274) | .020∗ | 1.532 | (1.062-2.208) | .022 | 1.085 | (0.669-1.759) | .740 | 2.030 | (1.124-3.668) | .019∗ |
| ECOG PS, ≥2 vs 0-1 | 3.049 | (1.721-5.403) | <.001∗ | 3.023 | (1.709-5.347) | <.001 | 1.663 | (0.757-3.654) | .206 | 1.754 | (0.605-5.079) | .301 |
| Cytogenetics of MPAL, BCR::ABL1-neg vs -pos | 1.639 | (1.019-2.636) | .042∗ | 1.641 | (1.046-2.574) | .031∗ | 1.384 | (0.741-2.586) | .308 | 1.651 | (0.854-3.193) | .136 |
| Disease status at transplant | ||||||||||||
| CR2 vs CR1 | 1.642 | (0.802-3.362) | .175 | 1.458 | (0.743-2.861) | .273 | 1.119 | (0.429-2.921) | .818 | 1.703 | (0.764-3.796) | .193 |
| CR3 or higher/nCR vs CR1 | 4.008 | (2.614-6.146) | <.001∗ | 3.644 | (2.426-5.475) | <.001∗ | 4.006 | (2.382-6.736) | <.001∗ | 1.027 | (0.493-2.140) | .943 |
| Conditioning | ||||||||||||
| TCI intermediate vs high | 1.067 | (0.652-1.744) | .796 | 1.160 | (0.733-1.836) | .526 | 0.856 | (0.381-1.926) | .707 | 1.305 | (0.695-2.448) | .408 |
| TCI low vs high | 2.493 | (1.212-5.129) | .013∗ | 2.587 | (1.190-5.622) | .016∗ | 2.233 | (0.648-7.693) | .203 | 1.434 | (0.371-5.535) | .601 |
neg, negative; pos, positive.